Bliss Gvs Pharma Limited announced earnings results for the third quarter ended December 31, 2018. For the third quarter, the company announced total revenue was INR 2,165.328 million compared to INR 1,982.577 million a year ago. Net income was INR 258.362 million compared to INR 179.207 million a year ago. Basic earnings per share was INR 2.5 compared to INR 1.74 a year ago. For the nine months, total revenue was INR 6,890.385 million compared to INR 6,690.345 million a year ago. Net income was INR 1,056.140 million compared to INR 731.008 million a year ago. Basic earnings per share was INR 10.24 compared to INR 7.09 a year ago.